Najat Khan sold $79K of Recursion Pharmaceuticals, Inc. (RXRX) stock

Najat Khan, CEO and President of Recursion Pharmaceuticals, Inc. (RXRX), sold 22,408 shares of RXRX stock worth $79K, per an SEC Form 4 filed Sep 10, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Sep 8, 2026, 2 days before it was made public.

RXRX has moved +15.4% since the trade date, from $3.44 to $3.97 (Sep 21, 2026 close).